Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.
about
Kinetic and Structural Characterization of the Interaction of 6-Methylidene Penem 2 with the β-Lactamase from Mycobacterium tuberculosisInhibition of OXA-1 beta-lactamase by penems.Insights into the environmental resistance gene pool from the genome sequence of the multidrug-resistant environmental isolate Escherichia coli SMS-3-5.Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypesInhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom.Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR.Phenotypic study of resistance of beta-lactamase-inhibitor-resistant TEM enzymes which differ by naturally occurring variations and by site-directed substitution at Asp276.Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase geneRisk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.Multiple clones within multidrug-resistant Salmonella enterica serotype Typhimurium phage type DT104. The Greek Nontyphoidal Salmonella Study Group.Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein.Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytocaRisk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients.Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes.Enumeration and characterization of antimicrobial-resistant Escherichia coli bacteria in effluent from municipal, hospital, and secondary treatment facility sourcesMultiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases.Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coliClinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.Molecular aspects of high-level resistance to sulbactam-cefoperazone in Klebsiella oxytoca clinical isolates.Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamaseProperties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases.Transferable hyperproduction of TEM-1 beta-lactamase in Shigella flexneri due to a point mutation in the pribnow box.Construction and characterization of an OHIO-1 beta-lactamase bearing Met69Ile and Gly238Ser mutations.Inhibitor-resistant TEM (IRT) beta-lactamases with different substitutions at position 244Extended-spectrum beta-lactamases in Ireland, including a novel enzyme, TEM-102.Resistance to beta-lactams--the permutations.Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli.Identification of Genome-Wide Mutations in Ciprofloxacin-Resistant F. tularensis LVS Using Whole Genome Tiling Arrays and Next Generation SequencingEmerging drugs for bacterial urinary tract infections.Quantifying nonspecific TEM beta-lactamase (blaTEM) genes in a wastewater streamVirtual Screening of compounds from Tabernaemontana divaricata for potential anti-bacterial activity.Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals.Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year periodMechanism of resistance to several antimicrobial agents in Salmonella Clinical isolates causing traveler's diarrhea.SHV-49, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Klebsiella pneumoniae.
P2860
Q28265806-CD22D680-7E18-4A6E-8E47-49ABE45600BAQ33344365-70D1647E-0F44-4C85-91C6-BD157BB1F119Q33360684-DAC47AFD-F5ED-4EF7-943F-C3D0812351E9Q33548223-C7315249-BAB2-4CA1-90B7-DE9F9743DFA5Q33647947-CF98937A-5153-465E-9544-4CC4311E6D47Q33680541-C6D0E3A8-549E-47BE-8BB3-AD99B5AD8C94Q33692735-25AE3A66-1029-48FC-8D07-74032E543674Q33693187-F8F4513A-4CCD-4DBA-880C-9078A1DE562DQ33693837-C9C1DBC2-52ED-42A4-9075-0EEC5E1E6D7AQ33971097-AC72E7E6-E254-4C27-ADBE-1E8260099193Q33974443-3049F77E-E8F1-4651-955E-41EE047DD3D3Q33976310-D74C3E25-3188-43B1-B3D2-072DCC006472Q33976916-2AE4D5B5-5ACE-4F9A-9934-0BE8F94517ACQ33977130-F7B2D24C-07F0-47B7-9B0C-E1267771FE7AQ33979185-5818CE26-9278-4179-A139-6079194E904EQ33980735-9809F9E3-B6B2-4B92-8848-A9B61A215EA8Q33983457-5698FF03-3020-457F-80E1-3744E373554EQ34092336-4D2B3687-D1DD-4951-BC6C-557E92A0AA73Q34252799-D3FE2380-E1BC-40B3-BD77-4790C6C72690Q34529235-89672713-DCBB-4BD2-8A26-45AA1CBD0107Q34594475-5BA315F2-EC67-4E80-8A58-37717977EB6DQ35126478-09975F15-F237-44E2-BEDA-7F17D136C78EQ35128617-76EC8AD1-E2F7-488A-ABA1-1C80426E61B9Q35132416-F75FDD98-3385-47A9-BFD3-F9450D7DEB05Q35132900-16AD4738-23EF-4B65-BAC7-2B72455823E4Q35138077-017B399F-4F4F-40DC-88DB-7111CC6C74FAQ35139062-469CB01C-607C-48A6-89FA-83DB9F818C49Q35166203-3040C332-0D73-44EF-BDF3-24369778CE51Q35681127-39746059-6834-4441-849F-E7303873B684Q36086480-6B7892A7-E6DD-436C-895A-A63413539725Q36144648-51A36E23-BBD7-4CBC-8372-80A07DD10C8DQ36150606-A65B0B8F-8696-4D00-B3A0-931297BC13F3Q37032925-B2883ECF-B294-4209-A133-E7397C385513Q38398329-A079D0D8-E542-43B9-B598-BAE19D4875F0Q39471431-14012384-FF2C-4FB3-A23F-733CAF600287Q39652959-E4441296-2A82-4F94-9F1E-147CE7878848Q39658035-93FE80A9-5180-44F2-B4E2-904D1D4B1C8EQ39671146-21B419C2-1968-4F1A-A1B5-3C57A46C106BQ40165873-CDDFF29A-6EAD-4079-BC0E-9B8F7686745EQ40289276-F47A66F3-A923-45B2-A80B-F413A4626A5D
P2860
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Incidence and mechanisms of re ...... anic acid in Escherichia coli.
@ast
Incidence and mechanisms of re ...... anic acid in Escherichia coli.
@en
type
label
Incidence and mechanisms of re ...... anic acid in Escherichia coli.
@ast
Incidence and mechanisms of re ...... anic acid in Escherichia coli.
@en
prefLabel
Incidence and mechanisms of re ...... anic acid in Escherichia coli.
@ast
Incidence and mechanisms of re ...... anic acid in Escherichia coli.
@en
P2093
P2860
P356
P1476
Incidence and mechanisms of re ...... anic acid in Escherichia coli.
@en
P2093
P2860
P304
P356
10.1128/AAC.39.11.2478
P407
P577
1995-11-01T00:00:00Z